Provided by Tiger Fintech (Singapore) Pte. Ltd.

Castle Biosciences, Inc.

18.91
+0.37002.00%
Post-market: 18.910.00000.00%16:04 EDT
Volume:335.52K
Turnover:6.29M
Market Cap:545.98M
PE:-102.51
High:19.06
Open:18.51
Low:17.89
Close:18.54
Loading ...
Aug 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 16, 2021

Major Issues Report

8-K - Current report
Jun 14, 2021

Major Issues Report

8-K - Current report
Jun 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
May 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2021

Major Issues Report

8-K - Current report
Apr 09, 2021

Major Issues Report

8-K - Current report
Mar 11, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 11, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 08, 2021

Major Issues Report

8-K - Current report
Feb 17, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 17, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 13, 2021

Major Issues Report

8-K - Current report
Dec 22, 2020

Major Issues Report

8-K - Current report
Dec 16, 2020

Major Issues Report

8-K - Current report
Dec 14, 2020

Major Issues Report

8-K - Current report